Want to see FATE full AI Analyst Report?
Fate Therapeutics (FATE) Q2 2026 Earnings Report
FATE Q2 2026 EPS Results
- Actual EPS
- -$0.25
- Consensus EPS
- -$0.27
- Beat/Miss
- Beat by +$0.02
- One Year Ago EPS
- -$0.29
FATE Q2 2026 Revenue Results
- Actual Revenue
- $2.08M
- Expected Revenue
- $1.34M
- Beat/Miss
- Beat by +$742.00K
- YoY Revenue Growth
- +9.18%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/13/2026
- Time
- Before Open
- Conference Call
- Thursday, August 13, 2026
FATE Upcoming Earnings
Fate Therapeutics's next earnings date is estimated for March 1, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
FATE Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 01, 2027 | 2026 (Q4) | ―- | -0.27 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | -0.27- | -0.27 | ― | |
| Aug 13, 2026 | 2026 (Q2) | -0.27-0.25 | -0.29 | 13.79% (+0.04) | |
| May 13, 2026 | 2026 (Q1) | -0.28-0.26 | -0.32 | 18.75% (+0.06) | |
| Feb 26, 2026 | 2025 (Q4) | -0.27-0.27 | -0.44 | 38.64% (+0.17) | |
| Nov 13, 2025 | 2025 (Q3) | -0.29-0.27 | -0.4 | 32.50% (+0.13) | |
| Aug 12, 2025 | 2025 (Q2) | -0.35-0.29 | -0.33 | 12.12% (+0.04) | |
| May 13, 2025 | 2025 (Q1) | -0.38-0.32 | -0.47 | 31.91% (+0.15) | |
| Mar 05, 2025 | 2024 (Q4) | -0.43-0.44 | -0.45 | 2.22% (+0.01) | |
| Nov 12, 2024 | 2024 (Q3) | -0.42-0.40 | -0.46 | 13.04% (+0.06) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
